SGI
LLY icon

Swan Global Investments’s Eli Lilly LLY Stock Holding History

Swan Global Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$831K Buy
693
+27
+4% +$27.6K 0.02% 60
2026
Q1 		$613K Buy
666
+23
+4% +$23.3K 0.02% 48
2025
Q4 		$691K Buy
643
+43
+7% +$41.1K 0.02% 48
2025
Q3 		$458K Buy
600
+38
+7% +$28.3K 0.01% 50
2025
Q2 		$438K Buy
562
+117
+26% +$90.9K 0.01% 45
2025
Q1 		$368K Buy
445
+167
+60% +$139K 0.01% 45
2024
Q4 		$215K Buy
+278
New +$230K 0.01% 51

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Swan Global Investments's LLY Position: Q2 2026 in Review

Swan Global Investments increased its Eli Lilly (LLY) stake by 4.1% in Q2 2026, buying an estimated $27.6K and bringing the position to 693 shares worth $831K. The position accounts for 0.02% of the portfolio, ranked #60.

Swan Global Investments first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Swan Global Investments held 693 shares of Eli Lilly worth $831K as of Q2 2026.
  • Swan Global Investments bought 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
  • Eli Lilly made up 0.02% of Swan Global Investments's portfolio in Q2 2026, its #60 holding.
  • Swan Global Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Swan Global Investments's 13F filing for Q2 2026, filed 11 Aug 2026.